肺鳞状细胞癌预后相关影响因素研究进展

doi:10.11904/j.issn.1002-3070.2021.04.016

Abstract

Abstract: Lung squamous cell carcinoma accounts for 20%~30% of lung cancer,causing about 400,000 deaths worldwide every year.The prognosis of patients with lung squamous cell carcinoma is poor,because patients often have advanced to advanced stage when they are diagnosed.There are many factors that affect the prognosis of lung squamous cell carcinoma,such as gender and smoking.This study reviewed the effects of own factors(smoking status,gender,age,BMI and complications),tumor factors(subsites and metastasis status)and treatment factors on the prognosis of lung squamous cell carcinoma.

Key words: Lung squamous cell carcinoma, Prognosis, Influencing factors

CLC Number:

R743.2

DONG Xiaoping, ZHANG Xue, GUO Dongli, HE Yutong. Research progress on the related factors affecting the prognosis of squamous cell carcinoma of lung[J]. Journal of Practical Oncology, 2021, 35(4): 380-385.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2021.04.016

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2021/V35/I4/380

References

1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2018,68(6):394-424.
2 Huang G,Huang Q,Xie Z,et al.A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcin oma [J].Cancer Biomark,2019,26(3):239-247.
3 Vachani A,Sequist LV,Spira A.AJRCCM:100-year anniversary.The shifting landscape for lung cancer:past,present,and future [J].Am J Respir Crit Care Med,2017,195(9):1150-1160.
4 Senoo S,Ninomiya K,Hotta K,et al.Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan [J].Int J Clin Oncol,2019,24(5):461-467.
5 Hata A,Nakajima T,Matsusaka K,et al.A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis [J].Int J Cancer,2020,146(2):388-399.
6 Jones CD,Cummings IG,Shipolini AR,et al.Does surgery improve prognosis in patients with small-cell lung carcinoma? [J].Interact Cardiovasc Thorac Surg,2013,16(3):375-380.
7 Socinski MA,Obasaju C,Gandara D,et al.Clinicopathologic features of advanced squamous NSCLC [J].J Thorac Oncol,2016,11(9):1411-1422.
8 Gu K,Lee HY,Lee K,et al.Integrated evaluation of clinical,pathological and radiological prognostic factors in squamous cell carcinoma of the lung [J].PLoS One,2019,14(10):e0223298.
9 Kadota K,Nitadori J,Woo KM,et al.Comprehensive pathological analyses in lung squamous cell carcinoma:single cell invasion,nuclear diameter,and tumor budding are independent prognostic factors for worse outcomes [J].J Thorac Oncol,2014,9(8):1126-1139.
10 Pesch B,Kendzia B,Gustavsson P,et al.Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies [J].Int J Cancer,2012,131(5):1210-1219.
11 Huang Y,Wang R,Pan Y,et al.Clinical and genetic features of lung squamous cell cancer in never-smokers [J].Oncotarget,2016,7(24):35979-35988.
12 Li J,Li H,Zhang C,et al.Integrative analysis of genomic alteration,immune cells infiltration and prognosis of lung squamous cell carcinoma(LUSC)to identify smoking-related biomarkers [J].Int Immunopharmacol,2020,89(Pt A):107053.
13 Poullis M,McShane J,Shaw M,et al.Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients [J].Eur J Cardiothorac Surg,2013,43(5):919-924.
14 Kinoshita FL,Ito Y,Morishima T,et al.Sex differences in lung cancer survival:long-term trends using population-based cancer registry data in Osaka,Japan [J].Jpn J Clin Oncol,2017,47(9):863-869.
15 Yoshida Y,Murayama T,Sato Y,et al.Gender differences in long-term survival after surgery for non-small cell lung cancer [J].Thorac Cardiovasc Surg,2016,64(6):507-514.
16 Radkiewicz C,Dickman PW,Johansson ALV,et al.Sex and survival in non-small cell lung cancer:A nationwide cohort study [J].PLoS One,2019,14(6):e0219206.
17 Chansky K,Sculie J,Crowley JJ,et al.The international association for the study of lung cancer staging project prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer [J].J Thorac Oncol,2010,4(7):792-801.
18 Watanabe K,Sakamaki K,Nishii T,et al.Gender differences in the recurrence timing of patients undergoing resection for non-small cell lung cancer [J].Asian Pac J Cancer Prev,2018,19(3):719-724.
19 Caldarella A,Crocetti E,Comin CE,et al.Gender differences in non-small cell lung cancer:a population-based study [J].Eur J Surg Oncol,2007,33(6):763-768.
20 Foegle J,Hedelin G,Lebitasy MP,et al.Specific features of non-small cell lung cancer in women:a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997 [J].J Thorac Oncol,2007,2(6):466-474.
21 Li F,He H,Qiu B,et al.Clinicopathological characteristics and prognosis of lung cancer in young patients aged 30 years and younger [J].J Thorac Dis,2019,11(10):4282-4291.
22 Yoneyama R,Saji H,Kato Y,et al.Clinicopathological characteristics and treatment strategies for young lung cancer patients [J].Ann Transl Med,2019,7(5):100.
23 Liu M,Cai X,Yu W,et al.Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old:a population-based study [J].Oncotarget,2015,6(42):44963-44970.
24 Antkowiak JG,Regal AM,Takita H.Bronchogenic carcinoma in patients under age 40[J].Elsevier,1989,47(3):391-393.
25 Zhong J,Zheng Q,Gao E,et al.Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinoma [J].Thorac Cancer,2018,9(2):291-297.
26 Fukumoto K,Mori S,Shintani Y,et al.Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer:a retrospective analysis of 16,503 cases in a Japanese lung cancer registry study [J].Lung Cancer,2020,149:120-129.
27 Xie HJ,Zhang X,Wei ZQ,et al.Effect of body mass index on survival of patients with stage I non-small cell lung cancer [J].Chin J Cancer,2017,36(1):7.
28 Morel H,Raynard B,d′Arlhac M,et al.Prediagnosis weight loss,a stronger factor than BMI,to predict survival in patients with lung cancer [J].Lung Cancer,2018,126(2018):55-63.
29 Gronberg BH,Sundstrom S,Kaasa S,et al.Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy [J].Eur J Cancer,2010,46(12):2225-2234.
30 Jorgensen TL,Hallas J,Friis S,et al.Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality [J].Br J Cancer,2012,106(7):1353-1360.
31 Wang W,Dou S,Dong W,et al.Impact of COPD on prognosis of lung cancer:from a perspective on disease heterogeneity [J].Int J Chron Obstruct Pulmon Dis,2018,13:3767-3776.
32 Li C,Wu W,Chen N,et al.Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema:a systematic review and meta-analysis of 13 studies [J].J Thorac Dis,2017,9(12):5322-5334.
33 Saijo T,Ishii G,Nagai K,et al.Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung [J].Lung Cancer,2006,52(1):37-45.
34 Kinoshita T,Ohtsuka T,Hato T,et al.Prognostic factors based on clinicopathological data among the patients with resected peripheral squamous cell carcinomas of the lung [J].J Thorac Oncol,2014,9(12):1779-1787.
35 Li C,Liu J,Lin J,et al.Poor survival of non-small-cell lung cancer patients with main bronchus tumor:a large population-based study [J].Future Oncol,2019,15(24):2819-2827.
36 Badawy A,Khedr G,Omar A,et al.Site of metastases as prognostic factors in unselected population of stage IV Non-small cell lung cancer [J].Asian Pac J Cancer Prev,2018,19(7):1907-1910.
37 Okauchi S,Watanabe H,Yamada H,et al.The prognosis of lung cancer with different metastatic patterns [J].Anticancer Res,2020,40(1):421-426.
38 Nakamura H,Sakai H,Kimura H,et al.Difference in postsurgical prognostic factors between lung adenocarcinoma and squamous cell carcinoma [J].Ann Thorac Cardiovasc Surg,2017,23(6):291-297.
39 Lin MW,Huang YL,Yang CY,et al.The differences in clinicopathologic and prognostic characteristics between surgically resected peripheral and central lung squamous cell carcinoma [J].Ann Surg Oncol,2019,26(1):217-229.
40 Tamiya M,Tamiya A,Inoue T,et al.Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer:a retrospective multicenter trial [J].PLoS One,2018,13(2):e0192227.
41 李晨蔚,励新健,周增辉.ⅢA期不同 N2 状态对肺鳞癌患者预后的影响 [J].浙江医学,2008,30(12):1350-1351.
42 Hilsenbeck S,Raub W,Sridhar K.Prognostic factors in lung cancer based on multivariate analysis [J].Am J Clin Oncol,1993,16(4):301-309.
43 Yang C,Wang H,Kumar A,et al.Impact of timing of lobectomy on survival for clinical stage IA lung squamous cell carcinoma [J].Chest,2017,152(6):1239-1250.
44 Kanzaki H,Kataoka M,Nishikawa A,et al.Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy [J].Int J Clin Oncol,2016,21(5):853-861.
45 Su L,Chen M,Su H,et al.Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis [J].BMC Cancer,2019,19(1):1023.
46 Wang J,Shen Q,Shi Q,et al.Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry [J].J Exp Clin Cancer Res,2014,33(109):109.
47 Calio A,Nottegar A,Gilioli E,et al.ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung [J].J Thorac Oncol,2014,9(5):729-732.
48 Rekhtman N,Paik PK,Arcila ME,et al.Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung:lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations [J].Clin Cancer Res,2012,18(4):1167-1176.
49 Soria J,Felip E,Cobo M,et al.Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung(LUX-Lung 8):an open-label randomised controlled phase 3 trial [J].The Lancet Oncology,2015,16(8):897-907.
50 Liu JH,Xu YM,Yan J.An 11-lncRNA risk scoring model predicts prognosis of lung squamous cell carcinoma [J].Eur Rev Med Pharmacol Sci,2020,24(10):5456-5464.

[1]	YU Youlin, YU Junlin, HU Chaohua, SHEN Xiongshan, LI Weimin, LU Ting, YANG Feng, YANG Qingqing, LIU Chenhao. Analysis for clinical prognostic value of LAYN in thyroid cancer and its influence on infiltration of immune cells [J]. Journal of Practical Oncology, 2021, 35(4): 357-364.
[2]	LIU Wen, QIAO Wenbo. Clinical research status of programmed cell death protein-1 and its ligand in colorectal cancer [J]. Journal of Practical Oncology, 2021, 35(4): 370-375.
[3]	YIN Lei, YANG Xudong, YANG Yue, NIU Xingjian, ZHOU Xiaoping, JI Hongfei, WANG Yiran. The clinical significance and related mechanism of neutrophil to lymphocyte ratio in the prognostic evaluation of patients with non small cell lung cancer [J]. Journal of Practical Oncology, 2021, 35(2): 117-124.
[4]	QIN Wei, HE Yifu, CHANG Na, QIAN Liting, HUANG Dabing, CUI Yayun. Effect of radiotherapy for locally advanced cervical cancer on rectal function [J]. Journal of Practical Oncology, 2021, 35(2): 170-173.
[5]	BI Jiaqing, QIN Qian, MA Huihan, MA Meijie, FENG Qinmei. Research progress of threonine and tyrosine kinase in tumor [J]. Journal of Practical Oncology, 2021, 35(2): 188-192.
[6]	ZHANG Lu,LU Jingyu,LU Haijun. The relationship between biomarkers of head and neck squamous cell carcinoma and prognosis of immunotherapy [J]. Journal of Practical Oncology, 2021, 35(1): 55-58.
[7]	DANG Yao,HUANG Fuhui,QIN Yixiao,CHE Qin,HAO Xiaolong,WANG Binquan. Research progress of metastatic mechanism and influencing factors of head and neck squamous cell carcinoma [J]. Journal of Practical Oncology, 2021, 35(1): 78-82.
[8]	NIU Ming, YU Ge. Gankyrin promotes tumor proliferation,metastasis and cancer stem cell characteristic in breast cancer [J]. Journal of Practical Oncology, 2020, 34(6): 518-523.
[9]	ZUO Rui, JIN Lu, LIU Li, LIU Xiaojia, ZHAO Pengyu, XIANG Xiaoyan. Research progress of miR-409-3p and tumor [J]. Journal of Practical Oncology, 2020, 34(6): 554-559.
[10]	LIU Hengchang, WEI Ran, LI Chunxiang, LIU Zheng, CHEN Haipeng, GUAN Xu, ZHAO Zhixun, ZOU Shuangmei, WANG Xishan, JIANG Zheng. Expression of NOX4 in colon cancer and its relationship with prognosis [J]. Journal of Practical Oncology, 2020, 34(5): 391-397.
[11]	SUN Xiaoyan, ZHANG Xiaoyan. Prognostic significance of lncRNA-SChLAP1 high-expression in colorectal cancer [J]. Journal of Practical Oncology, 2020, 34(5): 425-429.
[12]	YIN Songxiang. Expression of Copine-8 in gastric cancer and its correlations with clinicopathological features and prognosis [J]. Journal of Practical Oncology, 2020, 34(5): 430-435.
[13]	WEI Yong, ZHANG Yuhai, LV Shuangshuang, LI Yuemin. Effect of myasthenia gravis on prognosis of thymoma patients [J]. Journal of Practical Oncology, 2020, 34(4): 341-346.
[14]	XIE Xianxin,WEI Jun,QIU Jiaxin,WANG Cong,JIANG Daqing. Analysis of histopathological information and prognosis of residual tumor in neoadjuvant chemotherapy for breast cancer [J]. Journal of Practical Oncology, 2020, 34(3): 225-231.
[15]	WANG Zhao,FENG Yue,XING Linan,ZHANG Yunyan. Advances in the prognosis of PLR and malignant tumors with concurrent chemoradiotherapy [J]. Journal of Practical Oncology, 2020, 34(3): 271-275.

Research progress on the related factors affecting the prognosis of squamous cell carcinoma of lung

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments